No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BALY240517C12500
- 0.95
- 0.000.00%
15min DelayTrading May 2 15:07 ET
0.00High0.00Low
0.00Open0.95Pre Close0 Volume10.32K Open Interest12.50Strike Price0.00Turnover93.42%IV2.27%PremiumMay 17, 2024Expiry Date0.48Intrinsic Value100Multiplier3DDays to Expiry0.47Time Value100Contract SizeAmericanOptions Type0.6699Delta0.3074Gamma16.75Leverage Ratio-0.0671Theta0.0008Rho11.22Eff Leverage0.0046Vega
Intraday
- 5D
- 1D
News
Bally's Is Maintained at Hold by Stifel
Bally's Is Maintained at Hold by Stifel
Express News | Stifel Maintains Hold on Ballys, Raises Price Target to $14
Express News | Bally's Corp : Stifel Raises Target Price to $14 From $11
Earnings Call Summary | Ballys(BALY.US) Q1 2024 Earnings Conference
The following is a summary of the Bally's Corporation (BALY) Q1 2024 Earnings Call Transcript:Financial Performance:Bally's Corporation reported Q1 2024 revenues of $618 million, reflecting a 3% year-
Ballys Corp (BALY) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of Financial ...
Traffic Jams Are Denting Bally's Profits -- Market Talk
1839 ET - A partial bridge closure in Providence, R.I., is spelling trouble for Bally's. CEO Robeson Reeves says with 1Q results that construction on the Washington Bridge in Providence has hampered a
Comments
CEO Robeson Reeves is optimistic about the market's robustness and the long-term potential for the company's Casinos & Resorts assets. Despite this, shares are down more than 25% year-to-date.
Bally's Falls After Posting Another Unprofitable QuarterQ4 results fell short of estimates with disappointing revenue, operating margin, and EPS. The company's International Interactive segment underperformed. Analysts predict an increase in Bally's cash burn, implying a drop in its LTM free cash flow margin from negative 1.3% to negative 2.9%.
Gainers:
• $Ballys(BALY.US$ +6% (announces modified "Dutch auction" tender offer to purchase shares at $19.25-$22)
• $Ferguson(FERG.US$ +3.4% (enters entered into a non-discretionary arrangement with its brokers J.P. Morgan Securities in continuation of its $2 billion share repurchase program)
• $Bausch Health(BHC.US$ +3.3% (chairman resigns)
• $Sanofi(SNY.US$ +3.2% (Sanofi-GSK first to report a successful efficacy study against ...
• $Ballys(BALY.US$ +6% (announces modified "Dutch auction" tender offer to purchase shares at $19.25-$22)
• $Ferguson(FERG.US$ +3.4% (enters entered into a non-discretionary arrangement with its brokers J.P. Morgan Securities in continuation of its $2 billion share repurchase program)
• $Bausch Health(BHC.US$ +3.3% (chairman resigns)
• $Sanofi(SNY.US$ +3.2% (Sanofi-GSK first to report a successful efficacy study against ...
8
1
$Ballys(BALY.US$ The General has put in the bid of 38.00 per share for Ballys! There are 400,000 shorts that still have to cover. Surprised more people didn’t buy in on Guaranteed profit. Still not too late to make a small gain. I got in at 35.45. It could get interesting after 37.00. Hoping shorts cover in premarket. Who knows something crazy might happen, I mean it is Ballys.
5
4
Read more